Loading…
Loading…
PSYK (PSYK ETF) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
See exactly how PSYK's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PSYK and 80,000+ other tickers.
The fund's manager utilizes a passive investment strategy, aiming to closely mirror the returns of its target index. This benchmark is systematically constructed based on specific criteria, focusing on companies engaged in the legal development and application of psychedelic treatments for various medical conditions, adhering to the regulatory frameworks of the respective countries. Generally, the fund will acquire all of the index's constituent securities, maintaining portfolio weightings that approximate their representation within the index. It is important to note that this fund is non-diversified.
On July 13, 2022, two amendments passed in the House of Representatives that would provide psychedelic drug treatment to veterans and active duty service members. A documentary based on Michael Pollan's 2018 book, "How to Change Your Mind," is one of Netflix's most-watched shows.
A new thematic ETF providing exposure to the medicinal psychedelic drug industry, PSYK ETF, has just been launched.
Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF PSYK tracks the Enhanced Consciousness Index.
First-time issuer Elemental Advisors is the latest to create an ETF for the burgeoning industry.
Elemental Advisors just launched the PSYK ETF (NYSE Arca: PSYK), a thematic ETF focused on the emerging use of psychedelic compounds in treating mental health issues. Tim Collins, a founder and president of Elemental Advisors, recently provided some insight as to why the company decided to make this its first issued ETF, how the medicinal [.